CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- POS AM Other Post-effective Amendment for Registration Statement
- S-2 Other S-2
- 10-K Report Annual Report
- REGDEX Other REGDEX
- NT 10-K Other NT 10-K
- 8-K Event Acquisition or sale completed · New debt or obligation
- 8-K Event Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 8-K Event Unregistered share sale
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-2 Other S-2
Page 47 of 50 · 996 filings